Senolytic Drugs: Clearing Out Zombie Cells to Reverse Aging
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
20 articles
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
Explore the molecular mechanisms of cellular senescence and how p16/p21 pathways drive SASP production, plus cutting-edge senolytic drug targets.
A mechanistic deep-dive into cutting-edge anti-inflammaging interventions — from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.
Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions — from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches — that are redefining what's possible in cardiovascular longevity.
Discover how polyphenols from colorful fruits and vegetables protect your cells from damage and support healthy aging through powerful antioxidant mechanisms.
Explore how resveratrol activates sirtuins, the 'longevity proteins' that may slow aging and extend healthspan through cellular repair mechanisms.
Go beyond antioxidant basics to explore how polyphenols hijack transcription factor networks, remodel chromatin, and what randomized trials actually show about aging biomarkers.
Discover how 'zombie cells' in your body send harmful signals that spread aging from cell to cell — and what scientists are doing to stop them.
A mechanistic deep-dive into the molecular architecture of redox signaling — from cysteine oxidation chemistry to therapeutic targeting of NRF2, NADPH oxidases, and mitochondrial ROS in the context of aging.
Dive into the molecular machinery behind lifelong brain health — from BDNF-TrkB signaling cascades and adult hippocampal neurogenesis to glymphatic amyloid clearance and cutting-edge interventions including senolytics, GLP-1 agonists, and transcranial stimulation.
A deep mechanistic exploration of the signaling networks governing thymic involution and the most promising therapeutic strategies — from FOXN1 gene therapy to senolytics — entering clinical translation.
Master the cutting-edge molecular targets, clinical trial data, and emerging therapeutic strategies aimed at reversing ECM aging — from senolytic combinations to biomaterial scaffolds and epigenetic reprogramming.
A graduate-level exploration of CoQ10's electrochemical role in the electron transport chain — from semiquinone radical physics to supercomplex cryo-EM structures and next-generation mitochondrial therapeutics.
A deep mechanistic exploration of neutrophil extracellular trap biology in the context of aging — from PAD4 citrullination dynamics and gasdermin-driven release to clinical immunopathology and next-generation therapeutic targets.
Master the molecular machinery of sleep-dependent brain clearance, dissect melatonin's chronobiological role, and apply evidence-based protocols — from CBT-I to pharmacological aids — to engineer restorative sleep for longevity.
Explore the cutting-edge molecular architecture of the UPS — from E3 ligase conformational dynamics and proteasome regulatory networks to therapeutic exploitation via PROTACs, molecular glues, and deubiquitylase inhibitors.
A deep mechanistic exploration of how hypothalamic IKKβ/NF-κB signaling, htNSC exosomal communication, and multi-axis hormonal dysregulation drive systemic aging — plus cutting-edge therapeutic strategies.
Dissect the precise molecular architecture governing SASP regulation — from chromatin remodeling and cGAS-STING activation to extracellular vesicle-mediated spread and next-generation senolytic strategies.
Go beneath the surface of senescent cell biology to understand the precise molecular machinery driving the SASP — and how these signals corrupt neighboring cells, fuel inflammation, and accelerate tissue aging.
Master the cutting-edge molecular pharmacology of Wnt pathway modulation — from small-molecule β-catenin activators to senescence-driven inhibitor networks — and understand how researchers are translating these mechanisms into regenerative therapies.